Patheon posts surprise Q2 loss on delays and write-offs
Shares in Patheon slumped after delays, cancellations and inventory write-offs caused a drop in second quarter operating income.
Archives for June 14, 2011
GSK investing CA$30m & adding 70 jobs at Ontario plant
GlaxoSmithKline (GSK) is investing more than CA$30m (€21m) to add dermatology product manufacturing capabilities and create 70 jobs at a Canadian plant.
Tech to drive efficiencies as trials virtualise & automate
Visualisation and automation of clinical trials is set to continue as sponsors and CROs use technology to make studies more efficient.
Appointments at PhRMA, Dyax, Alnylam, Avi BioPharma, Pacira, Asmacure and Xceleon – People on the move
in-PharmaTechnologist.com presents its latest round up of movements in the pharma sector, including appointments at PhRMA, Dyax, Alnylam, Avi BioPharma, Pacira, Asmacure and Xceleon.